Evidence map›Paper›PMID 25636148›Full record

ArticleEnvironmental health perspectives2015

Arsenic exposure and prevalence of the varicella zoster virus in the United States: NHANES (2003-2004 and 2009-2010).

Andres Cardenas, Ellen Smit, E Andres Houseman, Nancy I Kerkvliet, Jeffrey W Bethel, Molly L Kile

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Continuing the Conversation About Arsenic.Integrative medicine (Encinitas, Calif.) · 2024
    Article
  2. Time to Recognize and Address the Serious Arsenic Problem.Integrative medicine (Encinitas, Calif.) · 2024
    Article
  3. Review
  4. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  5. The interplay between environmental exposures and COVID-19 risks in the health of children.Environmental health : a global access science source · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. The Unintended Consequences of a Gluten-free Diet.Epidemiology (Cambridge, Mass.) · 2017
    Article
  16. Arsenic: The Underrecognized Common Disease-inducing Toxin.Integrative medicine (Encinitas, Calif.) · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Andres CardenasSchool of Biological and Population Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, Oregon, USA.
Ellen Smit
E Andres Houseman
Nancy I Kerkvliet
Jeffrey W Bethel
Molly L Kile
Oregon State University · US

Funding

Research Experience and Training Coordination CoreP42ES016465 · NIEHS · OREGON STATE UNIVERSITY · PI Robyn L Tanguay · 2009 to 2026
$52.5M
Reducing Susceptibility to Environmental Stress Throughout the Life SpanP30ES000210 · NIEHS · OREGON STATE UNIVERSITY · PI BECKMAN, JOSEPH S · 1985 to 2015
$21.4M
Developmental Exposure to Arsenic and Immune Function in ChildrenR01ES023441 · NIEHS · OREGON STATE UNIVERSITY · PI KILE, MOLLY L · 2014 to 2018
$1.5M
Epigenetic Effects of Prenatal Arsenic Exposure and Fetal GrowthK01ES017800 · NIEHS · OREGON STATE UNIVERSITY · PI KILE, MOLLY L · 2010 to 2014
$529k
NIEHS NIH HHS K01 ES017800NIEHS NIH HHS K01ES017800NIEHS NIH HHS P30 ES000210NIEHS NIH HHS P30ES000210NIEHS NIH HHS P42 ES016465NIEHS NIH HHS P42ES016465NIEHS NIH HHS R01 ES023441NIEHS NIH HHS R01ES023441
6 · The paper itself

Abstract

backgroundArsenic is an immunotoxicant. Clinical reports observe the reactivation of varicella zoster virus (VZV) in people who have recovered from arsenic poisoning and in patients with acute promyelocytic leukemia that have been treated with arsenic trioxide.

objectiveWe evaluated the association between arsenic and the seroprevalence of VZV IgG antibody in a representative sample of the U.S.

methodsWe analyzed data from 3,348 participants of the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and 2009-2010 pooled survey cycles. Participants were eligible if they were 6-49 years of age with information on both VZV IgG and urinary arsenic concentrations. We used two measures of total urinary arsenic (TUA): TUA1 was defined as the sum of arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid, and TUA2 was defined as total urinary arsenic minus arsenobetaine and arsenocholine.

resultsThe overall weighted seronegative prevalence of VZV was 2.2% for the pooled NHANES sample. The geometric means of TUA1 and TUA2 were 6.57 μg/L and 5.64 μg/L, respectively. After adjusting for age, sex, race, income, creatinine, and survey cycle, odds ratios for a negative VZV IgG result in association with 1-unit increases in natural log-transformed (ln)-TUA1 and ln-TUA2 were 1.87 (95% CI: 1.03, 3.44) and 1.40 (95% CI: 1.0, 1.97), respectively.

conclusionsIn this cross-sectional analysis, urinary arsenic was inversely associated with VZV IgG seroprevalence in the U.S. POPULATION: This finding is in accordance with clinical observations of zoster virus reactivation from high doses of arsenic. Additional studies are needed to confirm the association and evaluate causal mechanisms.

Indexed as

Environmental ExposureAdolescentAdultAntibodies, ViralArsenicalsChickenpoxChildCross-Sectional StudiesEnvironmental MonitoringEnvironmental PollutantsFemaleHerpesvirus 3, HumanHumansImmunoglobulin GMaleMiddle AgedAntibodies, ViralArsenicalsEnvironmental PollutantsImmunoglobulin G

Identifiers

PMID25636148
PMCPMC4455594
OpenAlexW1969342231

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.